Status:
UNKNOWN
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the PREFER-PostPartum
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The risk of venous thromboembolism (VTE), which consists of deep vein thrombosis (DVT) and pulmonary embolism (PE), increases during pregnancy and most strikingly in the postpartum period (6 weeks aft...
Eligibility Criteria
Inclusion
- Women aged ≥18 years
- Ongoing pregnancy or in the early postpartum period (within 7 days of delivery)
- Participants may be with or without prior VTE or major bleeding, and with or without previous/current use of postpartum TPX.
- Fluency in French
- Women are able and willing to give free, informed and written consent
Exclusion
- Fetal or neonatal death, in order not to bother women during their mourning.
- Women under tutorship or curatorship
- Women deprived of liberty
- Women under court protection There will be no further exclusion criteria, to maximize the external validity of the study.
Key Trial Info
Start Date :
May 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05318547
Start Date
May 13 2022
End Date
December 31 2024
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014